#antibodies

Fred Hutch study suggests certain immune cells are the source of antibodies that attack donated organs.

NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.

A single vaccine dose delivered to nose aims to protect children and adults against COVID.

A mathematical technique called matrix completion could speed up the development of vaccines for flu and COVID-19 variants.

Extra vaccine doses, monoclonal antibodies and antivirals can help prevent severe illness.

Two treatment approaches using donor or engineered NK cells led to remission in people with lymphoma and leukemia.

Researchers urge survivors and their doctors to monitor heart health.

A new type of treatment uses antibodies to deliver cancer-fighting drugs directly to tumors.

Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.

New discoveries may show a way to save bone marrow cells and blood stem cells following chemotherapy.

Cancer patients undergoing treatment and those with suppressed immune systems eye the future—and the COVID pandemic’s wane—warily.

Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.

The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.

Evidence is growing that contracting SARS-CoV-2 is generally as effective as vaccination at preventing COVID-19.

People who received the Moderna COVID-19 vaccine had strong immune memory of SARS-CoV-2 six months after vaccination.

This is a good time to talk about how sleep can affect the body’s immune response to a vaccination.